Progress in Neurotherapeutics and Neuropsychopharmacology: Volume 1. 2006
Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including dis...
Gespeichert in:
Weitere beteiligte Personen: | |
---|---|
Format: | E-Book |
Sprache: | Englisch |
Veröffentlicht: |
Cambridge
Cambridge University Press
2006
|
Links: | https://doi.org/10.1017/CBO9780511663529 |
Zusammenfassung: | Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists. This volume was first published in 2006. |
Umfang: | 1 Online-Ressource (xiii, 169 Seiten) |
ISBN: | 9780511663529 |
Internformat
MARC
LEADER | 00000nam a2200000 i 4500 | ||
---|---|---|---|
001 | ZDB-20-CTM-CR9780511663529 | ||
003 | UkCbUP | ||
005 | 20151005020623.0 | ||
006 | m|||||o||d|||||||| | ||
007 | cr|||||||||||| | ||
008 | 091216s2006||||enk o ||1 0|eng|d | ||
020 | |a 9780511663529 | ||
245 | 0 | 0 | |a Progress in Neurotherapeutics and Neuropsychopharmacology |n Volume 1. |p 2006 |c edited by Jeffrey L. Cummings |
246 | 3 | |a Progress in Neurotherapeutics & Neuropsychopharmacology | |
264 | 1 | |a Cambridge |b Cambridge University Press |c 2006 | |
300 | |a 1 Online-Ressource (xiii, 169 Seiten) | ||
336 | |b txt | ||
337 | |b c | ||
338 | |b cr | ||
520 | |a Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists. This volume was first published in 2006. | ||
700 | 1 | |a Cummings, Jeffrey L. |d 1948- | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780521862530 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781107405875 |
966 | 4 | 0 | |l DE-91 |p ZDB-20-CTM |q TUM_PDA_CTM |u https://doi.org/10.1017/CBO9780511663529 |3 Volltext |
912 | |a ZDB-20-CTM | ||
912 | |a ZDB-20-CTM | ||
049 | |a DE-91 |
Datensatz im Suchindex
DE-BY-TUM_katkey | ZDB-20-CTM-CR9780511663529 |
---|---|
_version_ | 1825574052471767042 |
adam_text | |
any_adam_object | |
author2 | Cummings, Jeffrey L. 1948- |
author2_role | |
author2_variant | j l c jl jlc |
author_facet | Cummings, Jeffrey L. 1948- |
author_sort | Cummings, Jeffrey L. 1948- |
building | Verbundindex |
bvnumber | localTUM |
collection | ZDB-20-CTM |
format | eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01902nam a2200265 i 4500</leader><controlfield tag="001">ZDB-20-CTM-CR9780511663529</controlfield><controlfield tag="003">UkCbUP</controlfield><controlfield tag="005">20151005020623.0</controlfield><controlfield tag="006">m|||||o||d||||||||</controlfield><controlfield tag="007">cr||||||||||||</controlfield><controlfield tag="008">091216s2006||||enk o ||1 0|eng|d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511663529</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Progress in Neurotherapeutics and Neuropsychopharmacology</subfield><subfield code="n">Volume 1.</subfield><subfield code="p">2006</subfield><subfield code="c">edited by Jeffrey L. Cummings</subfield></datafield><datafield tag="246" ind1="3" ind2=" "><subfield code="a">Progress in Neurotherapeutics & Neuropsychopharmacology</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiii, 169 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists. This volume was first published in 2006.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cummings, Jeffrey L.</subfield><subfield code="d">1948-</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780521862530</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781107405875</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-91</subfield><subfield code="p">ZDB-20-CTM</subfield><subfield code="q">TUM_PDA_CTM</subfield><subfield code="u">https://doi.org/10.1017/CBO9780511663529</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CTM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CTM</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield></record></collection> |
id | ZDB-20-CTM-CR9780511663529 |
illustrated | Not Illustrated |
indexdate | 2025-03-03T11:58:06Z |
institution | BVB |
isbn | 9780511663529 |
language | English |
open_access_boolean | |
owner | DE-91 DE-BY-TUM |
owner_facet | DE-91 DE-BY-TUM |
physical | 1 Online-Ressource (xiii, 169 Seiten) |
psigel | ZDB-20-CTM TUM_PDA_CTM ZDB-20-CTM |
publishDate | 2006 |
publishDateSearch | 2006 |
publishDateSort | 2006 |
publisher | Cambridge University Press |
record_format | marc |
spelling | Progress in Neurotherapeutics and Neuropsychopharmacology Volume 1. 2006 edited by Jeffrey L. Cummings Progress in Neurotherapeutics & Neuropsychopharmacology Cambridge Cambridge University Press 2006 1 Online-Ressource (xiii, 169 Seiten) txt c cr Published annually, volumes in this series provide readers with updates of clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists. This volume was first published in 2006. Cummings, Jeffrey L. 1948- Erscheint auch als Druck-Ausgabe 9780521862530 Erscheint auch als Druck-Ausgabe 9781107405875 |
spellingShingle | Progress in Neurotherapeutics and Neuropsychopharmacology |
title | Progress in Neurotherapeutics and Neuropsychopharmacology |
title_alt | Progress in Neurotherapeutics & Neuropsychopharmacology |
title_auth | Progress in Neurotherapeutics and Neuropsychopharmacology |
title_exact_search | Progress in Neurotherapeutics and Neuropsychopharmacology |
title_full | Progress in Neurotherapeutics and Neuropsychopharmacology Volume 1. 2006 edited by Jeffrey L. Cummings |
title_fullStr | Progress in Neurotherapeutics and Neuropsychopharmacology Volume 1. 2006 edited by Jeffrey L. Cummings |
title_full_unstemmed | Progress in Neurotherapeutics and Neuropsychopharmacology Volume 1. 2006 edited by Jeffrey L. Cummings |
title_short | Progress in Neurotherapeutics and Neuropsychopharmacology |
title_sort | progress in neurotherapeutics and neuropsychopharmacology 2006 |
work_keys_str_mv | AT cummingsjeffreyl progressinneurotherapeuticsandneuropsychopharmacologyvolume1 AT cummingsjeffreyl progressinneurotherapeuticsneuropsychopharmacology |